On Wednesday, the European Commission gave a conditional marketing authorization for Moderna’s coronavirus vaccine in the European Union, following an approval from the European Medicines Agency earlier in the day. While the decision will need a confirmation by the European Commission, it still facilitates the vaccine distribution process in the coming days.
Ursula von der Leyen, president of the European Commission, said in a statement that the Moderna vaccine would allow the EU to have an additional 160 million doses. The European Medicines Agency said the biotech's mRNA 1273 vaccine is "another tool to overcome the current emergency", after the Pfizer-BioNTech Covid vaccine.
The decision will need a confirmation by the European Commission